Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy. Read more about Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy.
The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy. Read more about The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy.
Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Read more about Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
More evidence that physical activity is beneficial for prostate cancer. Read more about More evidence that physical activity is beneficial for prostate cancer.
Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth. Read more about Exercise in advanced prostate cancer elevates myokine levels and suppresses in-vitro cell growth.
Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate. Read more about Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate.
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics. Read more about Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.
Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database. Read more about Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database.
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer. Read more about PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative. Read more about Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative.
